4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022055
Sr. VP, New Prod. Strat. & Dev sold 2,125 shares at $9.63 ($20,464)
From the SEC's structured data for this filing
Trades in this filing
Kieffer Tara Lynn · Sr. VP, New Prod. Strat. & Dev
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-05 | Sale : show line 1 in the form | −2,125 | $9.63 | $20,464 | 37,260 | D |
| Open-market sales · 2,125 sh · avg $9.63 · $20,464 | ||||||
Loading xslF345X05/form4.xml…